Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00720551
Other study ID # 07-374
Secondary ID
Status Completed
Phase N/A
First received July 18, 2008
Last updated February 12, 2009
Start date June 2008
Est. completion date February 2009

Study information

Verified date February 2009
Source Utrecht Institute for Pharmaceutical Sciences
Contact n/a
Is FDA regulated No
Health authority Netherlands: Medical Ethics Review Committee (METC)
Study type Interventional

Clinical Trial Summary

The aim of this study is to calibrate the STISIM driving simulator under influence of three different dosages of ethanol (0.05%, 0.08% and 0.11% BAC). The levels of performance decrement for the three blood alcohol concentrations will serve as a standard for comparing the effects that will be observed with psychoactive drugs in future trials. This will make the results of these future studies more easily to interpret and will provide health care providers and policy makers who read our scientific work with an easy-to-understand and clinically relevant comparison.


Recruitment information / eligibility

Status Completed
Enrollment 27
Est. completion date February 2009
Est. primary completion date February 2009
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 21 Years to 50 Years
Eligibility Inclusion Criteria:

- 21-50 years old

- Written informed consent

- Normal static binocular acuity, corrected or uncorrected

- Normal hearing

- Social Drinker (average of 7 to 21 alcoholic drinks per week and experience with drinking 4-6 drinks per occasion)

- No current or past drug use

- Possession of a driver's license for at least 3 years

- Be considered as reliable and mentally capable of adhering to the protocol

Exclusion Criteria:

- Current and past drug use (positive urine drug screen on the presence of amphetamines (including MDMA), barbiturates, cannabinoids, benzodiazepines, cocaine, and opiates)

- Positive urine pregnancy screen in women

- Present use of psychoactive medication

- Positive alcohol breath test

- Prior enrollment in the same study

- Physical or mental illness

- Excessive alcohol use ( > 21 alcoholic drinks per week)

- Excessive smoking (more than 10 cigarettes per day)

- Intake of caffeine-containing beverages over 5 glasses per day

- Simulator sickness, as determined during the training session

Study Design

Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject)


Related Conditions & MeSH terms


Intervention

Other:
alcohol
alcohol 0.05%, 0.08% or 0.11% or placebo

Locations

Country Name City State
Netherlands Utrecht University, Section Psychopharmacology Utrecht

Sponsors (1)

Lead Sponsor Collaborator
Utrecht Institute for Pharmaceutical Sciences

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Primary Standard Deviation of the Lateral Position (SDLP) one day No
Secondary Number of collisions and traffic violations 20 minutes No